Glass House Brands Inc.

OTCPK:GLAS.F Stock Report

Market Cap: US$552.3m

Glass House Brands Valuation

Is GLAS.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GLAS.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GLAS.F ($7.14) is trading below our estimate of fair value ($74.67)

Significantly Below Fair Value: GLAS.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GLAS.F?

Key metric: As GLAS.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GLAS.F. This is calculated by dividing GLAS.F's market cap by their current revenue.
What is GLAS.F's PS Ratio?
PS Ratio2.9x
SalesUS$188.29m
Market CapUS$552.30m

Price to Sales Ratio vs Peers

How does GLAS.F's PS Ratio compare to its peers?

The above table shows the PS ratio for GLAS.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.8x
THRN Thorne HealthTech
2.1x19.8%US$550.6m
HNST Honest Company
2.2x5.7%US$840.0m
HKHC Horizon Kinetics Holding
13.4xn/aUS$723.1m
WALD Waldencast
1.5x18.2%US$409.7m
GLAS.F Glass House Brands
2.9x15.3%US$552.3m

Price-To-Sales vs Peers: GLAS.F is good value based on its Price-To-Sales Ratio (2.9x) compared to the peer average (5.7x).

Price to Sales Ratio vs Industry

How does GLAS.F's PS Ratio compare vs other companies in the US Personal Products Industry?

26 CompaniesPrice / SalesEstimated GrowthMarket Cap
HLF Herbalife
0.2x1.8%US$796.26m
NUS Nu Skin Enterprises
0.2x-0.06%US$369.85m
MED Medifast
0.3x-13.4%US$195.14m
SKIN Beauty Health
0.5x5.7%US$177.49m
GLAS.F 2.9xIndustry Avg. 1.5xNo. of Companies26PS02.44.87.29.612+
26 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: GLAS.F is expensive based on its Price-To-Sales Ratio (2.9x) compared to the US Personal Products industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is GLAS.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GLAS.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.9x
Fair PS Ratio1.9x

Price-To-Sales vs Fair Ratio: GLAS.F is expensive based on its Price-To-Sales Ratio (2.9x) compared to the estimated Fair Price-To-Sales Ratio (1.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GLAS.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$7.14
US$11.44
+60.2%
3.9%US$12.00US$11.00n/a4
Nov ’25US$7.80
US$12.23
+56.7%
6.6%US$13.00US$11.00n/a4
Oct ’25US$8.84
US$12.30
+39.1%
7.5%US$13.00US$11.00n/a3
Sep ’25US$8.36
US$12.38
+48.1%
7.9%US$13.15US$11.00n/a3
Aug ’25US$8.23
US$12.58
+52.7%
4.6%US$13.15US$12.00n/a2
Jul ’25US$6.99
US$12.58
+79.9%
4.6%US$13.15US$12.00n/a2
Jun ’25US$7.80
US$12.58
+61.2%
4.6%US$13.15US$12.00n/a2
May ’25US$9.42
US$9.50
+0.8%
5.3%US$10.00US$9.00n/a2
Apr ’25US$8.50
US$9.50
+11.8%
5.3%US$10.00US$9.00n/a2
Mar ’25US$6.98
US$7.78
+11.4%
22.8%US$9.55US$6.00n/a2
Apr ’24US$2.81
US$5.50
+95.7%
9.1%US$6.00US$5.00US$8.502
Mar ’24US$2.87
US$5.50
+91.6%
9.1%US$6.00US$5.00US$6.982
Feb ’24US$2.50
US$5.50
+120.0%
9.1%US$6.00US$5.00US$6.302
Jan ’24US$1.91
US$5.50
+188.0%
9.1%US$6.00US$5.00US$4.732

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Beauty Health

US$177.5m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.47

7D

-1.3%

1Y

-41.7%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.2b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.F

Mex$1.37

7D

0.4%

1Y

n/a

Shiseido Company

JP¥1.1t

Engages in the production and sale of cosmetics in Japan and internationally.

SSDO.F

JP¥19.60

7D

0%

1Y

-30.9%